FDA to review surgical staplers after thousands of reports of malfunctions

इंडिया समाचार समाचार

FDA to review surgical staplers after thousands of reports of malfunctions
इंडिया ताज़ा खबर,इंडिया मुख्य बातें
  • 📰 CNN
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 95%

The FDA announced a sweeping plan to review and address the safety of surgical staplers after thousands of reports of malfunctions

In a letter sent to health care providers Friday, the FDA said it will convene an advisory meeting on the safety of the devices and signaled that it might reclassify surgical staplers to put them under tighter control. The agency also said it plans to issue proposed recommendations to companies that make the devices, which are used in countless surgeries.

"Improving the safety of surgical staplers and implantable staples is a top priority for the FDA, and we believe our forthcoming draft guidance to industry and planned advisory committee meeting will advance those efforts," Maisel said.

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

CNN /  🏆 4. in US

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

FDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorFDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorGottlieb worked in the healthcare industry before joining the Food and Drug Administration as its top official during the Trump administration.
और पढो »

Nasal spray drug related to ketamine approved by FDA to treat depressionNasal spray drug related to ketamine approved by FDA to treat depressionThe FDA approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression.
और पढो »

FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionFDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.
और पढो »

FDA moves on vaping, drugs and food at risk with chief’s departureFDA moves on vaping, drugs and food at risk with chief’s departureFDA Commissioner Scott Gottlieb was an outlier in the Trump administration, with an activist agenda touching everything from medical device regulation to youth smoking. His departure puts it all in jeopardy
और पढो »

Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
और पढो »

Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
और पढो »

FDA calls Walgreens' sale of tobacco to minors 'disturbing'FDA calls Walgreens' sale of tobacco to minors 'disturbing'The Food and Drug Administration says Walgreens sells more tobacco products to minors than any other pharmacy chain. Now the agency wants to meet with the company to discuss its tobacco and e-cigarette sales policies.
और पढो »

FDA Commissioner Gottlieb, who raised alarms about teen vaping, resignsFDA Commissioner Gottlieb, who raised alarms about teen vaping, resignsFDA Commissioner Scott Gottlieb, who raised national alarms about teenage vaping, is resigning
और पढो »



Render Time: 2025-02-28 11:56:27